Potential Biomarkers in Systemic Sclerosis: A Literature Review and Update
Systemic sclerosis (SSc) is a chronic autoimmune disease characterized by dysregulation of the immune system, vascular damage, and fibrosis of the skin and internal organs. Patients with SSc show a heterogeneous phenotype and a range of clinical courses. Therefore, biomarkers that are helpful for pr...
Main Authors: | Akira Utsunomiya, Noritaka Oyama, Minoru Hasegawa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/11/3388 |
Similar Items
-
Editorial: Etiopathogenesis of Systemic Sclerosis: An Update
by: Giuseppina Stifano, et al.
Published: (2021-03-01) -
Proposition of a novel animal model of systemic sclerosis induced by type V collagen in C57BL/6 mice that reproduces fibrosis, vasculopathy and autoimmunity
by: Walcy Rosolia Teodoro, et al.
Published: (2019-12-01) -
Identification of Biomarkers in Cerebrospinal Fluid and Serum of Multiple Sclerosis Patients by Immunoproteomics Approach
by: Paolo Colomba, et al.
Published: (2014-12-01) -
Biomarkers in scleroderma: Current status
by: Latika Gupta, et al.
Published: (2017-01-01) -
Biomarkers for Pulmonary Vascular Remodeling in Systemic Sclerosis: A Pathophysiological Approach
by: Balazs Odler, et al.
Published: (2018-06-01)